Moolec Science Announces Strategic Business Combination with Bioceres Group

Moolec Science ( (MLEC) ) has shared an update.

On April 17, 2025, Moolec Science SA announced a strategic business combination with Bioceres Group Limited, Gentle Technologies Corp, and Nutrecon LLC, positioning Moolec as the parent company. This move aims to consolidate holdings and issue new shares and warrants to the shareholders of the contributed entities. The combination is expected to restructure the corporate framework, with Moolec transitioning its jurisdiction to the Cayman Islands. The agreement includes issuing shares and warrants, adjusting share ratios, and implementing a holdback amount to cover potential liabilities, reflecting Moolec’s strategic growth and market expansion efforts.

Spark’s Take on MLEC Stock

According to Spark, TipRanks’ AI Analyst, MLEC is a Neutral.

Moolec Science faces financial and operational challenges despite strong revenue growth. High leverage and negative cash flow highlight financial instability. The technical analysis suggests bearish sentiment, with oversold signals but no clear recovery signs. Unfavorable valuation metrics further contribute to the stock’s low score, reflecting significant risks in the company’s financial and operational outlook.

To see Spark’s full report on MLEC stock, click here.

More about Moolec Science

Moolec Science SA operates in the biotechnology industry, focusing on innovative solutions through strategic business combinations. The company is a public limited liability entity based in Luxembourg, with its shares and warrants listed on Nasdaq. Moolec is involved in a business combination with Bioceres Group Limited, Gentle Technologies Corp, and Nutrecon LLC to enhance its market position.

YTD Price Performance: -17.56%

Average Trading Volume: 17,578

Technical Sentiment Signal: Buy

Current Market Cap: $28.49M

Find detailed analytics on MLEC stock on TipRanks’ Stock Analysis page.